Harvard Bioscience (HBIO) Reports Q4 EPS of $0.02
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $6.67 --0%
Financial Fact:
Basic earnings per common share: -0.05
Today's EPS Names:
CMCT, STEX, PWCM, More
Financial Fact:
Basic earnings per common share: -0.05
Today's EPS Names:
CMCT, STEX, PWCM, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q4 EPS of $0.02, versus ($0.02) reported last year. Revenue for the quarter came in at $33.1 million, versus $31 million reported last year.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
